title: Estimating the nucleated red blood cell 'emergence time' in neonates.
abstract: OBJECTIVE
  The time between onset of fetal hypoxia and first appearance of nucleated red blood cells (NRBCs) in the blood can conceptually be divided into two periods; (1) the 'erythropoietin (EPO) generation time', which previous fetal studies suggest is 4 to 5 h, and (2) the 'NRBC emergence time'. In this study, we estimated the latter as the time required for NRBC to appear in the blood after administering a dose of recombinant EPO.
  
  
  METHODS
  This was a retrospective analysis of data from a multihospital healthcare system (Intermountain Healthcare). Data were included only for neonates born ≥34 weeks gestation between the dates 1 January 2005 and 31 October 2012 and only if they received a dose of darbepoetin during their neonatal intensive care unit stay and had one or more complete blood cell counts (CBCs) obtained during the 3-day period before the dose was given and one or more CBCs in the 7-day period after the dose.
  
  
  RESULTS
  The study involved 31 neonates who received 34 doses of darbepoetin. Seven doses were 4 μg kg(-1) and twenty-seven doses were 10 μg kg(-1). Twenty-six CBCs were obtained during the 24-h period following the darbepoetin dose and none had NRBC identified. NRBC first appeared in the blood between 24 and 36 h after the dose. Recipients of the higher dose generally had a higher peak NRBC count but the NRBC 'emergence time' did not appear to depend on dose.
  
  
  CONCLUSIONS
  Following fetal hypoxia, transcription and translation of the EPO gene result in an elevation in plasma EPO concentration. Previous fetal studies suggest this process requires 4 to 5 h. The present studies suggest that, following the increase in plasma EPO, NRBC emerge into the circulation in ≥24 h. If this model serves as a reasonable estimate, it suggests that neonates with an elevated NRBC count at birth had the onset of hypoxia at least 28 to 29 h before birth.
authors.affiliation: Department of Women and Newborns, Intermountain Healthcare, Salt Lake City, UT, USA.
authors.forename: R D
authors.initials: RD
authors.lastname: Christensen
authors.affiliation: Department of Women and Newborns, Intermountain Healthcare, Salt Lake City, UT, USA.
authors.forename: D K
authors.initials: DK
authors.lastname: Lambert
authors.affiliation: 1] Department of Women and Newborns, Intermountain Healthcare, Salt Lake City, UT, USA [2] Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Richards
mesh_terms: D001772:Blood Cell Count; D000068256:Darbepoetin alfa; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D005311:Fetal Hypoxia / Q000097:blood*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D004921:Erythropoietin; D000068256:Darbepoetin alfa
references.citation: Blood. 2007 Feb 1;109(3):868-73
references.pmid: 17032916
references.citation: Arch Iran Med. 2010 Jul;13(4):275-81
references.pmid: 20597559
references.citation: Methods Mol Biol. 2013;982:13-41
references.pmid: 23456860
references.citation: Am J Obstet Gynecol. 2008 Apr;198(4):426.e1-9
references.pmid: 18395034
references.citation: J Matern Fetal Neonatal Med. 2007 May;20(5):377-80
references.pmid: 17674240
references.citation: Blood Cells Mol Dis. 2010 Jan 15;44(1):1-6
references.pmid: 19836979
references.citation: Obstet Gynecol. 1993 Sep;82(3):353-8
references.pmid: 8355933
references.citation: J Perinatol. 2006 May;26(5):296-300
references.pmid: 16554846
references.citation: Neonatology. 2009;95(2):105-16
references.pmid: 18776724
references.citation: Pediatr Int. 2002 Dec;44(6):590-5
references.pmid: 12421253
references.citation: Int J Gynaecol Obstet. 2003 Jun;81(3):267-71
references.pmid: 12767568
references.citation: J Biol Chem. 2006 Sep 1;281(35):25703-11
references.pmid: 16787915
references.citation: J Perinatol. 2005 Nov;25(11):725-30
references.pmid: 16151471
references.citation: J Clin Invest. 2007 Apr;117(4):1068-77
references.pmid: 17404621
references.citation: J Perinatol. 2006 Oct;26(10):636-9
references.pmid: 16929342
references.citation: Biol Neonate. 2004;85(4):217-20
references.pmid: 14691347
references.citation: Am J Obstet Gynecol. 2005 May;192(5):1427-9
references.pmid: 15902127
references.citation: Am J Obstet Gynecol. 1999 Dec;181(6):1500-5
references.pmid: 10601935
references.citation: Am J Physiol Cell Physiol. 2011 Jun;300(6):C1215-22
references.pmid: 21368293
references.citation: Neonatology. 2011;99(4):289-94
references.pmid: 21135564
references.citation: Am J Obstet Gynecol. 2007 Sep;197(3):286.e1-8
references.pmid: 17826423
references.citation: Pediatrics. 2012 May;129(5):e1165-72
references.pmid: 22508916
references.citation: Arch Dis Child Fetal Neonatal Ed. 2005 Mar;90(2):F174-5
references.pmid: 15724047
references.citation: Blood. 1999 Sep 15;94(6):1864-77
references.pmid: 10477715
references.citation: Pediatr Res. 1986 Jan;20(1):15-9
references.pmid: 3945512
references.citation: Pediatrics. 1995 Sep;96(3 Pt 1):475-8
references.pmid: 7651781